A new study is out that compares the effectiveness of two popular weight loss drugs, Wegovy and Zepbound. The study, which was conducted by Eli Lilly, the maker of Zepbound, found that weight loss ...

Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nor ...

President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to ...

Trendy weight-loss drugs making headlines for shrinking waistlines may also be shrinking the human heart and other muscles, ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

Ah, Thanksgiving: a time to gather ’round with friends and family, reflect on what we’re grateful for, and, of course, eat.

Bonnie Chapman — the 25-year-old daughter of Duane "Dog the Bounty Hunter" Chapman — revealed she's taking tirzepatide for ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...